Evidence map›Paper›PMID 36289434›Full record

ArticleScientific reports2022

Small-scale (sub-organ and cellular level) alpha-particle dosimetry methods using an iQID digital autoradiography imaging system.

Robin Peter, Brenda M Sandmaier, Michael P Dion, Sofia H L Frost, Erlinda B Santos, Aimee Kenoyer, Donald K Hamlin, D Scott Wilbur, Robert D Stewart, Darrell R Fisher and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Compton Imaging of Ac-225 In Pre-clinical Phantoms With a 3D-positioning CZT Camera.IEEE transactions on radiation and plasma medical sciences · 2026
    Article
  3. Article
  4. Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Robin PeterDepartment of Nuclear Engineering, University of California, Berkeley, CA, USA. rpeter@berkeley.edu.
Brenda M SandmaierFred Hutchinson Cancer Center, Seattle, WA, USA.
Michael P DionOak Ridge National Laboratory, Oak Ridge, TN, USA.
Sofia H L FrostFred Hutchinson Cancer Center, Seattle, WA, USA.
Erlinda B SantosFred Hutchinson Cancer Center, Seattle, WA, USA.
Aimee KenoyerFred Hutchinson Cancer Center, Seattle, WA, USA.
Donald K HamlinDepartment of Radiation Oncology, University of Washington, Seattle, WA, USA.
D Scott WilburDepartment of Radiation Oncology, University of Washington, Seattle, WA, USA.
Robert D StewartDepartment of Radiation Oncology, University of Washington, Seattle, WA, USA.
Darrell R FisherVersant Medical Physics and Radiation Safety, Richland, WA, USA.
Kai VetterDepartment of Nuclear Engineering, University of California, Berkeley, CA, USA.
Youngho SeoDepartment of Nuclear Engineering, University of California, Berkeley, CA, USA.
Brian W MillerDepartment of Radiation Oncology, Department of Medical Imaging, College of Medicine, University of Arizona, Tucson, AZ, USA.
Fred Hutch Cancer Center · USUniversity of California, Berkeley · USUniversity of Washington · USOak Ridge National Laboratory · USUniversity of Arizona · USUniversity of Washington Medical Center · US

Funding

Project 3: Stem Cell Allografts for Lymphoid MalignanciesP01CA078902 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI SANDMAIER, BRENDA MARIE · 1999 to 2025
$46.1M
Project 3: Gene Therapy for Correction of Blood DisordersP01HL122173 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KIEM, HANS-PETER · 2015 to 2019
$12.9M
[18F]F-AraG as an imaging biomarker for early diagnosis and monitoring of cardiotoxicity related to doxorubicin and immune check point inhibitor therapyR01HL160688 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jelena Levi, Youngho Seo · 2022 to 2026
$3.4M
Alpha Radioimmunotherapy for Lymphoma TreatmentR01CA172582 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI SANDMAIER, BRENDA MARIE · 2013 to 2018
$3.2M
Energy-independent single photon molecular imaging technologyR01EB026331 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CUI, YONGGANG, SEO, YOUNGHO · 2018 to 2022
$2.6M
NCI NIH HHS P01 CA078902NCI NIH HHS R01 CA172582NHLBI NIH HHS P01 HL122173NHLBI NIH HHS R01 HL160688NIBIB NIH HHS R01 EB026331
6 · The paper itself

Abstract

Targeted radiopharmaceutical therapy with alpha-particle emitters (αRPT) is advantageous in cancer treatment because the short range and high local energy deposition of alpha particles enable precise radiation delivery and efficient tumor cell killing. However, these properties create sub-organ dose deposition effects that are not easily characterized by direct gamma-ray imaging (PET or SPECT). We present a computational procedure to determine the spatial distribution of absorbed dose from alpha-emitting radionuclides in tissues using digital autoradiography activity images from an ionizing-radiation quantum imaging detector (iQID). Data from

Indexed as

Alpha ParticlesRadiopharmaceuticalsAnimalsAntibodies, MonoclonalAutoradiographyDogsRadioisotopesRadiometryAntibodies, MonoclonalRadioisotopesRadiopharmaceuticals

Identifiers

PMID36289434
PMCPMC9606121
OpenAlexW4307565222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.